Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS

13.39 Up 0.08(0.60%) May 24, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 7,603   12,728   5,102   21,863  
Cost of Revenue -   -   -   -  
Gross Profit 7,603   12,728   5,102   21,863  
Operating Expenses
Research Development22,332  21,540  20,233  20,010  
Selling General and Administrative9,716  9,373  10,999  12,355  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (24,445) (18,185) (26,130) (10,502)
Income from Continuing Operations
Total Other Income/Expenses Net329  508  308  335  
Earnings Before Interest And Taxes(24,116)(17,677)(25,822)(10,167)
Interest Expense -   -   -   -  
Income Before Tax(24,116)(17,677)(25,822)(10,167)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(24,116)(17,677)(25,822)(10,167)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (24,116) (17,677) (25,822) (10,167)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (24,116) (17,677) (25,822) (10,167)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.